These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27138587)

  • 21. The moderating effect of family involvement on substance use risk factors in adolescents with severe emotional and behavioral challenges.
    Schlauch RC; Levitt A; Connell CM; Kaufman JS
    Addict Behav; 2013 Jul; 38(7):2333-42. PubMed ID: 23584195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adolescent Initiation of Cannabis Use and Early-Onset Psychosis.
    Bagot KS; Milin R; Kaminer Y
    Subst Abus; 2015; 36(4):524-33. PubMed ID: 25774457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent change in alcohol and drug problems among treated adolescents over three years.
    Chung T; Martin CS; Clark DB
    J Stud Alcohol Drugs; 2008 May; 69(3):420-9. PubMed ID: 18432385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substance abuse and psychosis.
    Goerke D; Kumra S
    Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):643-54. PubMed ID: 24012078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence.
    Harley M; Kelleher I; Clarke M; Lynch F; Arseneault L; Connor D; Fitzpatrick C; Cannon M
    Psychol Med; 2010 Oct; 40(10):1627-34. PubMed ID: 19995476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabis and psychosis. Is there epidemiological evidence for an association?
    Thornicroft G
    Br J Psychiatry; 1990 Jul; 157():25-33. PubMed ID: 2204462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
    Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
    J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aripiprazole for treating cannabis-induced psychotic symptoms in ultrahigh-risk individuals.
    Rolland B; Geoffroy PA; Jardri R; Cottencin O
    Clin Neuropharmacol; 2013; 36(3):98-9. PubMed ID: 23673914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychiatric disorders induced by drug dependence other than alcohol].
    Lejoyeux M; Mourad I; Ades J
    Encephale; 2000; 26(2):21-7. PubMed ID: 10858911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute Mental Health Symptoms in Adolescent Marijuana Users.
    Levy S; Weitzman ER
    JAMA Pediatr; 2019 Feb; 173(2):185-186. PubMed ID: 30556823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis-induced psychosis associated with high potency "wax dabs".
    Pierre JM; Gandal M; Son M
    Schizophr Res; 2016 Apr; 172(1-3):211-2. PubMed ID: 26876313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis and psychiatric disorders.
    Loga S; Loga-Zec S; Spremo M
    Psychiatr Danub; 2010 Jun; 22(2):296-7. PubMed ID: 20562767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance use and cognition in early psychosis.
    Pencer A; Addington J
    J Psychiatry Neurosci; 2003 Jan; 28(1):48-54. PubMed ID: 12587850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review.
    Wilson L; Szigeti A; Kearney A; Clarke M
    Schizophr Res; 2018 Jul; 197():78-86. PubMed ID: 29117908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
    McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
    JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical course in severe catatonic schizophrenia in a cannabis-dependent male adolescent: a case report.
    Håkansson A; Johansson BA
    J Med Case Rep; 2015 Sep; 9():200. PubMed ID: 26388066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse effects of cannabis.
    Prescrire Int; 2011 Jan; 20(112):18-23. PubMed ID: 21462790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between adolescent marijuana use and young adult illicit drug use.
    Lessem JM; Hopfer CJ; Haberstick BC; Timberlake D; Ehringer MA; Smolen A; Hewitt JK
    Behav Genet; 2006 Jul; 36(4):498-506. PubMed ID: 16565887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Atypical course of combined cannabis-atropine abuse].
    Wiesbeck GA; Methfessel J; Täschner KL
    Nervenarzt; 1989 Aug; 60(8):516-7. PubMed ID: 2797336
    [No Abstract]   [Full Text] [Related]  

  • 40. Cumulative and recent psychiatric symptoms as predictors of substance use onset: does timing matter?
    Cerdá M; Bordelois PM; Keyes KM; Galea S; Koenen KC; Pardini D
    Addiction; 2013 Dec; 108(12):2119-28. PubMed ID: 23941263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.